Letrozole tops tamoxifen for early breast cancer (Reuters)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/nm/20051229/hl_nm/breast_cancer_dc"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/rids/20051229/i/r2542262978.jpg?x=130&y=92&sig=3XdaylCOLVQEtooVYmspqg--" align="left" height="92" width="130" alt="A woman is seen receiving a mammogram in Glendale, California in this undated file photo. As add-on therapy for breast cancer, letrozole appears to be more effective than tamoxifen in reducing the risk of the disease recurring, new research suggests. REUTERS/Handout" border="0" /></a>Reuters - As add-on therapy for breast
cancer, letrozole appears to be more effective than tamoxifen
in reducing the risk of the disease recurring, new research
suggests.</p><br clear=all>